跳至主要内容
临床试验/CTRI/2023/01/048696
CTRI/2023/01/048696尚未招募3 期

Comparison of two vaginal preparations of micronized progesterone for prevention of recurrent preterm birth (effervescent vaginal tablet and gelatin capsule): A Randomized Controlled Trial

Post Graduate Institute of Medical Education and Research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Singleton live pregnancy between 16 to 20 weeks.
  • 2. At least one spontaneous mid-trimester abortion or preterm birth (>=16 weeks PoG to <37 weeks PoG) of a singleton infant due to spontaneous Preterm labor or Preterm premature rupture of membranes.

排除标准

  • 1.Multifetal gestation
  • 2.Known allergy to progesterone
  • 3.Women with medical disorders (severe chronic hypertension, diabetes mellitus, heart disease, severe anaemia, collagen vascular disorders) which require additional treatment or may result in Preterm delivery
  • 4.Major congenital malformation of the fetus.
  • 5.Women with short cervical length (<= 25 mm)
  • 6.Women with current cerclage

研究者

发起方
Post Graduate Institute of Medical Education and Research

相似试验